blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1501931

EP1501931 - CHIMERIC SNRNA MOLECULES CARRYING ANTISENSE SEQUENCES AGAINST THE SPLICE JUNCTIONS OF THE DYSTROPHIN GENE AND THEIR THERAPEUTIC APPLICATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.09.2010
Database last updated on 24.04.2024
Most recent event   Tooltip14.09.2012Lapse of the patent in a contracting state
New state(s): HU
published on 17.10.2012  [2012/42]
Applicant(s)For all designated states
UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA"
Piazzale Aldo Moro 5
00185 Roma / IT
[2009/23]
Former [2005/05]For all designated states
UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA"
P.le Aldo Moro 5
00185 Roma / IT
Inventor(s)01 / BOZZONI, I. Dipt. Genetica e Biologia Molecolare
Università Degli Studi di Roma- La Sapienza
Piazzale Aldo Moro, 5 I-00185 Roma / IT
02 / DE ANGELIS, F.G. Dipt. Genetica e Biologia Molecolare
Università Degli Studi di Roma- La Sapienza
Piazzale Aldo Moro, 5 I-00185 Roma / IT
 [2009/47]
Former [2005/05]01 / BOZZONI, I. Dipt. Genetica e Biologia Molecolare
Università Degli Studi di Roma- La Sapienza
Piazzale Aldo Moro, 5 I-00185 Roma / IT
02 / DE ANGELIS, F.G. Dipt. Genetica e Biol. Molecolare
Università Degli Studi di Roma- La Sapienza
Piazzale Aldo Moro, 5 I-00185 Roma / IT
Representative(s)Capasso, Olga, et al
De Simone & Partners S.r.l.
Via Vincenzo Bellini, 20
00198 Roma / IT
[N/P]
Former [2005/05]Capasso, Olga, et al
de Simone & Partners SpA Via V.Bellini 20
00198 Roma / IT
Application number, filing date03749984.506.05.2003
[2005/05]
WO2003IT00273
Priority number, dateIT2002RM0025308.05.2002         Original published format: IT RM20020253
[2005/05]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03095647
Date:20.11.2003
Language:EN
[2003/47]
Type: A2 Application without search report 
No.:EP1501931
Date:02.02.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 20.11.2003 takes the place of the publication of the European patent application.
[2005/05]
Type: B1 Patent specification 
No.:EP1501931
Date:18.11.2009
Language:EN
[2009/47]
Search report(s)International search report - published on:EP19.02.2004
ClassificationIPC:C12N15/11, A61K48/00
[2005/05]
CPC:
C12N15/113 (EP); A61K38/00 (EP); A61K48/00 (EP);
C07K2319/00 (EP); C12N2310/111 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/05]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:CHIMÄRE SNRNA MOLEKÜLE MIT ANTISENSE-SEQUENZEN GEGEN DIE "SPLICE JUNCTIONS" DES DYSTROPHIN-GENS UND IHRE THERAPEUTISCHEN VERWENDUNGEN[2009/19]
English:CHIMERIC SNRNA MOLECULES CARRYING ANTISENSE SEQUENCES AGAINST THE SPLICE JUNCTIONS OF THE DYSTROPHIN GENE AND THEIR THERAPEUTIC APPLICATIONS[2005/05]
French:MOLECULES DE SNARN CHIMERES PORTANT DES SEQUENCES ANTISENS CONTRE LES JONCTIONS D'EPISSAGE DU GENE DE LA DYSTROPHINE ET APPLICATIONS THERAPEUTIQUES ASSOCIEES[2005/05]
Former [2005/05]CHIMERISCHE SNRNA MOLEKÜLE MIT ANTISENSE-SEQUENZEN GEGEN DIE "SPLICE JUNCTIONS" DES DYSTROPHIN-GENS UND IHRE THERAPEUTISCHE VERWENDUNGEN
Entry into regional phase26.11.2004National basic fee paid 
26.11.2004Designation fee(s) paid 
26.11.2004Examination fee paid 
Examination procedure26.11.2004Examination requested  [2005/05]
25.04.2005Despatch of a communication from the examining division (Time limit: M06)
26.10.2005Reply to a communication from the examining division
24.07.2007Despatch of a communication from the examining division (Time limit: M04)
24.10.2007Reply to a communication from the examining division
18.12.2007Despatch of a communication from the examining division (Time limit: M04)
19.02.2008Reply to a communication from the examining division
27.03.2008Despatch of a communication from the examining division (Time limit: M04)
20.05.2008Reply to a communication from the examining division
11.05.2009Communication of intention to grant the patent
15.09.2009Fee for grant paid
15.09.2009Fee for publishing/printing paid
Divisional application(s)EP09176221.1  / EP2151497
Opposition(s)19.08.2010No opposition filed within time limit [2010/43]
Fees paidRenewal fee
06.04.2005Renewal fee patent year 03
03.05.2006Renewal fee patent year 04
23.04.2007Renewal fee patent year 05
07.05.2008Renewal fee patent year 06
23.03.2009Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ18.11.2009
EE18.11.2009
RO18.11.2009
SK18.11.2009
BG18.02.2010
HU19.05.2010
[2012/42]
Former [2010/39]CZ18.11.2009
EE18.11.2009
RO18.11.2009
SK18.11.2009
BG18.02.2010
Former [2010/36]CZ18.11.2009
EE18.11.2009
RO18.11.2009
BG18.02.2010
Former [2010/35]EE18.11.2009
RO18.11.2009
BG18.02.2010
Cited inInternational search[Y]EP1191097  (LEIDS UNI MEDISCH CT [NL]) [Y] 7-12,15,16 * claims 1-6 *;
 [XDY]  - GORMAN ET AL., "Restoration of Correct Splicing of Thalassemic ß-Globin Pre-mRNA by modified U1 snRNAs", J BIOL CHEM, (20001117), vol. 275, no. 46, pages 35914 - 35919, XP002261981 [XD] 1-6,13,14 * abstract * * the whole document * [Y] 7-12,15,16

DOI:   http://dx.doi.org/10.1074/jbc.M006259200
 [Y]  - M. MATSUO, "Duchenne and Becker Muscular Dystrophy: From Gene Diagnosis to Molecular Therapy", IUBMB LIFE, (200203), vol. 53, no. 3, pages 147 - 152, XP009021242 [Y] 7-12,15,16 * Summary; Figure 1; Table 1 *

DOI:   http://dx.doi.org/10.1080/15216540212333
 [Y]  - DEUTEKOM VAN J C T ET AL, "Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, GB, (2001), vol. 10, no. 15, ISSN 0964-6906, pages 1547 - 1554, XP002250908 [Y] 7-12,15,16 * the whole document *

DOI:   http://dx.doi.org/10.1093/hmg/10.15.1547
 [YD]  - MANN C J ET AL, "ANTISENSE-INDUCED EXON SKIPPING AND SYNTHESIS OF DYSTROPHIN IN THE MDX MOUSE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, (20010102), vol. 98, no. 1, ISSN 0027-8424, pages 42 - 47, XP001160821 [YD] 7-12,15,16 * abstract * * pages 46-47 *

DOI:   http://dx.doi.org/10.1073/pnas.011408598
 [AD]  - SUTER D ET AL, "DOUBLE-TARGET ANTISENSE U7 SNRNAS PROMOTE EFFICIENT SKIPPING OF AN ABERRANT EXON IN THREE HUMAN BETA-THALASSEMIC MUTATIONS", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, GB, (199912), vol. 8, ISSN 0964-6906, pages 2415 - 2423, XP000973208 [AD] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1093/hmg/8.13.2415
 [PX]  - DE ANGELIS FERNANDA GABRIELLA ET AL, "Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. UNITED STATES 9 JUL 2002, (20020709), vol. 99, no. 14, ISSN 0027-8424, pages 9456 - 9461, XP002261982 [PX] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.142302299
 [PX]  - BRUN C ET AL, "U7 snRNAs induce correction of mutated dystrophin pre-mRNA by exon skipping.", CMLS CELLULAR AND MOLECULAR LIFE SCIENCES, (200303), vol. 60, no. 3, ISSN 1420-682X, pages 557 - 566, XP009021235 [PX] 1-4 * the whole document *

DOI:   http://dx.doi.org/10.1007/s000180300047
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.